Celcuity (CELC) Competitors $12.46 +0.46 (+3.83%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CELC vs. FTRE, VRDN, AHCO, CDNA, PNTG, AVAH, AGL, CSTL, GRAL, and INNVShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include Fortrea (FTRE), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), agilon health (AGL), Castle Biosciences (CSTL), Grail (GRAL), and InnovAge (INNV). These companies are all part of the "healthcare" industry. Celcuity vs. Fortrea Viridian Therapeutics AdaptHealth CareDx The Pennant Group Aveanna Healthcare agilon health Castle Biosciences Grail InnovAge Celcuity (NASDAQ:CELC) and Fortrea (NASDAQ:FTRE) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations. Does the media prefer CELC or FTRE? In the previous week, Celcuity had 2 more articles in the media than Fortrea. MarketBeat recorded 5 mentions for Celcuity and 3 mentions for Fortrea. Celcuity's average media sentiment score of 0.99 beat Fortrea's score of 0.48 indicating that Celcuity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Fortrea 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is CELC or FTRE more profitable? Celcuity has a net margin of 0.00% compared to Fortrea's net margin of -10.99%. Fortrea's return on equity of 2.00% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets CelcuityN/A -62.66% -39.78% Fortrea -10.99%2.00%0.80% Do analysts rate CELC or FTRE? Celcuity currently has a consensus price target of $29.17, indicating a potential upside of 134.08%. Fortrea has a consensus price target of $23.30, indicating a potential upside of 20.98%. Given Celcuity's stronger consensus rating and higher probable upside, equities analysts plainly believe Celcuity is more favorable than Fortrea.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Celcuity 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14Fortrea 1 Sell rating(s) 11 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.92 Do institutionals & insiders believe in CELC or FTRE? 63.3% of Celcuity shares are owned by institutional investors. 15.8% of Celcuity shares are owned by insiders. Comparatively, 0.1% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor CELC or FTRE? Celcuity received 326 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 67.54% of users gave Celcuity an outperform vote while only 25.58% of users gave Fortrea an outperform vote. CompanyUnderperformOutperformCelcuityOutperform Votes33767.54% Underperform Votes16232.46% FortreaOutperform Votes1125.58% Underperform Votes3274.42% Which has better valuation & earnings, CELC or FTRE? Fortrea has higher revenue and earnings than Celcuity. Fortrea is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCelcuityN/AN/A-$63.78M-$2.61-4.77Fortrea$2.98B0.58-$3.40M-$3.42-5.63 Which has more volatility and risk, CELC or FTRE? Celcuity has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. Comparatively, Fortrea has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. SummaryCelcuity beats Fortrea on 13 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.I call it my AI Retirement Playbook. I recommend you check it out now. Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$462.64M$2.93B$5.14B$9.08BDividend YieldN/A15.63%5.09%4.23%P/E Ratio-4.7716.0290.0517.18Price / SalesN/A284.461,117.14116.99Price / CashN/A472.1143.0437.86Price / Book2.275.194.784.78Net Income-$63.78M-$32.86M$120.31M$225.60M7 Day Performance-0.48%-3.01%-1.92%-1.23%1 Month Performance-2.36%2.96%11.51%3.36%1 Year Performance-14.89%12.37%30.61%16.60% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity2.6094 of 5 stars$12.46+3.8%$29.17+134.1%-13.6%$462.64MN/A-4.7740News CoverageHigh Trading VolumeFTREFortrea2.6058 of 5 stars$20.13+0.7%$23.30+15.7%-41.0%$1.81B$3.11B-5.8518,000VRDNViridian Therapeutics2.9514 of 5 stars$22.50+26.1%$36.33+61.5%-6.9%$1.78B$310,000.00-5.2950Analyst ForecastGap DownHigh Trading VolumeAHCOAdaptHealth2.3386 of 5 stars$10.14+6.2%$11.67+15.1%+58.4%$1.36B$3.26B-5.7910,700Positive NewsCDNACareDx3.591 of 5 stars$22.68-0.8%$29.60+30.5%+90.5%$1.22B$280.32M-8.35740Positive NewsPNTGThe Pennant Group4.5661 of 5 stars$29.75+2.2%$38.25+28.6%+100.7%$1.02B$544.89M42.815,791Analyst ForecastNews CoveragePositive NewsAVAHAveanna Healthcare0.9169 of 5 stars$5.00-0.6%$4.27-14.7%+82.5%$966.13M$1.98B-14.7933,500Positive NewsAGLagilon health2.3055 of 5 stars$2.25+0.4%$4.28+90.4%-84.0%$927.04M$5.59B-2.381,117Gap DownCSTLCastle Biosciences2.7304 of 5 stars$28.77-0.3%$39.71+38.0%+34.4%$805.76M$311.88M144.35540Insider TradeGRALGrail0.4714 of 5 stars$22.91+3.4%$16.00-30.2%N/A$769.80M$117.67M0.001,360Gap DownINNVInnovAge1.2807 of 5 stars$4.45+0.2%$6.50+46.1%-25.4%$602.78M$786.51M-37.002,350Analyst ForecastNews Coverage Related Companies and Tools Related Companies Fortrea Competitors Viridian Therapeutics Competitors AdaptHealth Competitors CareDx Competitors The Pennant Group Competitors Aveanna Healthcare Competitors agilon health Competitors Castle Biosciences Competitors Grail Competitors InnovAge Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CELC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CELC Stock Alerts